We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current ATRA market cap is 67.37M. The company's latest EPS is USD -2.2566 and P/E is -0.30.
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 4.46M | 221k | 1.23M | 957k | 2.14M |
Operating Income | -84.62M | -75.54M | -75.02M | -71.63M | -72.72M |
Net Income | -84.09M | -76.27M | -74.77M | -71.11M | -69.8M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 20.34M | 63.57M |
Operating Income | -237.11M | -295.68M | -309.05M | -340.46M | -280.51M |
Net Income | -230.7M | -290.98M | -306.62M | -340.14M | -230M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 368.32M | 376.42M | 302.08M | 246.44M | 188.79M |
Total Liabilities | 181.2M | 249.78M | 237.12M | 238.99M | 239.63M |
Total Equity | 187.11M | 126.64M | 64.96M | 7.45M | -50.84M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 391.84M | 342.94M | 588.12M | 468.13M | 376.42M |
Total Liabilities | 52.98M | 52.16M | 125.78M | 188.51M | 249.78M |
Total Equity | 338.86M | 290.78M | 462.34M | 279.61M | 126.64M |
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -213.55M | -270.43M | -38.43M | -91.23M | -142.57M |
Investing | 151.74M | 202.96M | -6.01M | 43.48M | 113.92M |
Financing | 20.79M | 53.08M | 235k | 706k | 498k |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -179.77M | -235.63M | -180.76M | -220.52M | -270.43M |
Investing | -196.29M | 60.46M | -120.73M | 22.26M | 202.96M |
Financing | 357.54M | 188.79M | 427.57M | 103.94M | 53.08M |
Market Cap | 67.37M |
Price to Earnings Ratio | -0.30 |
Price to Sales Ratio | 1.07 |
Price to Cash Ratio | 0.73 |
Price to Book Ratio | 0.54 |
Dividend Yield | - |
Shares Outstanding | 101.92M |
Average Volume (1 week) | 1.12M |
Average Volume (1 Month) | 1.15M |
52 Week Change | -77.21% |
52 Week High | 3.06 |
52 Week Low | 0.1986 |
Spread (Intraday) | 0.09 (12.02%) |
Company Name | Atara Biotherapeutics Inc |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.atarabio.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions